Description:
AZD-5363 is an orally available inhibitor of the serine/threonine protein kinase AKT (protein kinase B) with potential antineoplastic activity. AZD-5363 binds to and inhibits all AKT isoforms. This agent may be used as monotherapy or combination therapy for a variety of human cancers.
- Molecular Weight: 4.289.152
- Molecular Formula: C21H25ClN6O2
Purity: 98%
Canonical SMILES:
C1CN(CCC1(C(=O)NC(CCO)C2=CC=C(C=C2)Cl)N)C3=NC=NC4=C3C=CN4
InChI:
InChI=1S/C21H25ClN6O2/c22-15-3-1-14(2-4-15)17(6-12-29)27-20(30)21(23)7-10-28(11-8-21)19-16-5-9-24-18(16)25-13-26-19/h1-5,9,13,17,29H,6-8,10-12,23H2,(H,27,30)(H,24,25,26)/t17-/m0/s1
InChIKey: JDUBGYFRJFOXQC-KRWDZBQOSA-N
- Appearance: white solid powder
Synonyms:
AZD5363; AZD 5363; Capivasertib
More details are to be found on supplier website
